Nanjing, China

Shang Li

This inventor holds 1 USPTO granted patent. Top assignees: Nanjing Xingang Medical Co., Ltd., Nanjing Yoko Biomedical R & D Ltd., Nanjing Yoko Pharmaceutical Co., Ltd.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shang Li. Retrieved from https://idiyas.com/inventor/shang-li-go1jwrmg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shang Li

Introduction

Shang Li is a notable inventor based in Nanjing, China. He has made significant contributions to the field of biomedical research, particularly in the development of histone deacetylase inhibitors. His work has implications for the treatment of various diseases related to the dysregulation of HDAC.

Latest Patents

Shang Li holds a patent for "Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments." This invention provides histone deacetylase (HDAC) inhibitors represented as Formula I, where R to R are defined in the specification. The patent also outlines methods for synthesizing these compounds and their applications in preparing pharmaceuticals aimed at preventing or treating mammal diseases associated with HDAC dysregulation. He has 1 patent to his name.

Career Highlights

Throughout his career, Shang Li has worked with various organizations, including Nanjing Yoko Biomedical R&D Ltd. and Nanjing Xingang Medical Co., Ltd. His experience in these companies has allowed him to advance his research and contribute to the field of medicine.

Collaborations

Shang Li has collaborated with notable coworkers such as Sheng Jiang and Zhiyi Yao. Their combined expertise has furthered the development of innovative solutions in biomedical research.

Conclusion

Shang Li's contributions to the field of histone deacetylase inhibitors highlight his role as an influential inventor in the biomedical sector. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…